The use of orthopaedic shoes in patients with diabetes at high risk of foot amputation and Charcot arthropathy

被引:0
|
作者
Demina, A. G. [1 ,2 ]
Bregovskiy, V. B. [1 ,2 ]
Karpova, I. A. [2 ]
机构
[1] Federal North West Med Res Ctr, St Petersburg, Russia
[2] City Diabet Ctr, St Petersburg, Russia
来源
DIABETES MELLITUS | 2015年 / 18卷 / 04期
关键词
diabetes mellitus; diabetic foot; orthopedic footwear; diabetic neuroosteoarthropathia; Charcot foot;
D O I
10.14341/DM7186
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Aim. To evaluate the use of orthopaedic shoes in patients with diabetes with foot ulcers and/or previous minor amputations or Charcot arthropathy (CA) and factors influencing this use. Patients and methods. One hundred twenty-one patients with diabetes (55 men and 66 women; 36 in the inactive stage of CA) were included. A questionnaire based on footwear was used to evaluate patients' compliance. Daily activity and the severity of the foot deformities were recorded. Further, foot geometry and forefoot and midfoot circumferences were measured. Results. Fifty-eight patients did not use orthopaedic shoes. Users and non-users did not differ in terms of gender and type of diabetes. The causes of refusal included ill-fitting shoes (56%), ugly appearance (11%), traumatisation with shoes (11%), inability to walk (5%) and other causes (17%). The percentages of patients in each category of deformity severity were mild (41.2%), moderate (37%) and severe (54%. Frequency of refusal of CA vs non-CA patients: 72.2% and 43.5%; with severe deformities, 70.8% vs 34%; with moderate deformities, 83.3% vs 57.2% (p < 0.05 for all). In patients with CA, the only significant parameter was the difference in the circumference of the midfoot between the affected and non-affected foot; in CA users and non-users, this parameter was 1.93 +/- 1.25 vs 0.70 +/- 0.83 cm, respectively (p = 0.01). Conclusions. The high frequency of refusing to wear orthopaedic shoes is related to severe foot deformities and the inability to accommodate them in off-the-shelf footwear. Most of the patients used orthopaedic shoes for outdoor use, but the frequency of use was low. Shoe compliance did not depend on gender but increased with ageing, low levels of daily activity and in patients with severe deformities. Patients with CA are characterised with extremely low compliance. In this group, foot parameters and other objective parameters did not rely on footwear compliance.
引用
收藏
页码:79 / 86
页数:8
相关论文
共 50 条
  • [21] The prevalence of the Charcot foot in at risk diabetic patients
    Galstyan, G
    Tokmakova, A
    Maiorov, A
    Antsiferov, M
    Dedov, I
    DIABETOLOGIA, 1996, 39 : 997 - 997
  • [22] Outcomes Following Surgical Correction of Talocalcalcaneal Joint Dislocation in Diabetes Associated Charcot Foot Arthropathy
    Cho, Elizabeth
    Pinzur, Michael S.
    Schiff, Adam P.
    Hamid, Kamran
    FOOT & ANKLE INTERNATIONAL, 2024,
  • [23] Bone Mineral Density in Type 2 Diabetes Patients with Charcot Arthropathy
    El Oraby, Hussein A.
    Abdelsalam, Mona M.
    Eid, Yara M.
    El Hilaly, Rana
    Marzouk, Heba A.
    CURRENT DIABETES REVIEWS, 2019, 15 (05) : 395 - 401
  • [24] Prevalence, incidence and risk factors for Charcot foot in patients with diabetes: a nationwide Swedish study
    Tsatsaris, G.
    Ekberg, N. Rajamand
    Fall, T.
    Catrina, S.
    DIABETOLOGIA, 2022, 65 (SUPPL 1) : S11 - S11
  • [25] Ocular Manifestations and Neuropathy in Type 2 Diabetes Patients With Charcot Arthropathy
    Trindade, Marilia
    de Vasconcelos, Jessica Castro
    Ayub, Gabriel
    Grupenmacher, Alex Treiger
    Gomes Huarachi, Delma Regina
    Viturino, Marina
    Correa-Giannella, Maria Lucia
    Atala, Yeelen Ballesteros
    Zantut-Wittmann, Denise Engelbrecht
    Parisi, Maria Candida
    Alves, Monica
    FRONTIERS IN ENDOCRINOLOGY, 2021, 12
  • [26] How Common Is the Rare Charcot Foot in Patients With Diabetes?
    Svendsen, Ole Lander
    Rabe, Oliver Christian
    Winther-Jensen, Matilde
    Allin, Kristine Hojgaard
    DIABETES CARE, 2021, 44 (04) : E62 - E63
  • [27] Cost Comparison: Limb Salvage Versus Amputation in Diabetic Patients With Charcot Foot
    Gil, Joseph
    Schiff, Adam P.
    Pinzur, Michael S.
    FOOT & ANKLE INTERNATIONAL, 2013, 34 (08) : 1097 - 1099
  • [28] Higher systemic inflammatory status and cardiovascular risk associated with Charcot arthropathy unrelated to infection or extremity amputation
    Jessica Castro de Vasconcelos
    Yeelen Ballesteros Atala
    Denise Engelbrecht Zantut-Wittmann
    Maria Cândida Ribeiro Parisi
    Journal of Diabetes & Metabolic Disorders, 2022, 21 : 1407 - 1413
  • [29] Increased Risk of Nonunion and Charcot Arthropathy After Ankle Fracture in People With Diabetes
    Lavery, Lawrence A.
    Lavery, David C.
    Green, Tyson
    Hunt, Nathan
    La Fontaine, Javier
    Kim, Paul J.
    Wukich, Dane
    JOURNAL OF FOOT & ANKLE SURGERY, 2020, 59 (04): : 653 - 656
  • [30] Risk assessment of amputation in patients with diabetic foot
    Tanasescu, Denisa
    Sabau, Dan
    Moisin, Andrei
    Gherman, Claudia
    Fleaca, Radu
    Bacila, Ciprian
    Mohor, Calin
    Tanasescu, Ciprian
    EXPERIMENTAL AND THERAPEUTIC MEDICINE, 2023, 25 (01)